Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Depression and Anxiety|October 11, 2005
Multidimensional effects of sertraline in social anxiety disorderKathryn M Connor, Jonathan R T Davidson, Henry Chung, et al.Comprehensive Psychiatry|December 6, 2005
Trauma and posttraumatic stress in users of the Anxiety Disorders Association of America Web sitePeter J Nicholls, Kurian Abraham, Kathryn M Connor, et al.Psychopharmacology|December 13, 2005
Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatmentKathryn M Connor, Jonathan R T Davidson, Richard H Weisler, et al.The Clinical Journal of Pain|April 28, 2017
Orexin Receptor Antagonism in Painful Diabetic Neuropathy: A Phase 2 Trial With FilorexantW Joseph Herring, Joy Y Ge, Saheeda Jackson, et al.The Journal of Clinical Psychiatry|January 27, 2005
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patientsKathryn M Connor, Victoria M Payne, Kishore M Gadde, et al.Psychiatry Research|March 30, 2007
Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scaleKathryn M Connor, Sandeep Vaishnavi, Jonathan R T Davidson, et al.The Journal of Nervous and Mental Disease|January 28, 2005
Predictors of posttraumatic outcomes following the 1999 Taiwan earthquakeChia-Ming Chang, Kathryn M Connor, Te-Jen Lai, et al.Journal of Psychiatric Research|March 9, 2004
Full and partial PTSD among earthquake survivors in rural TaiwanTe-Jen Lai, Chia-Ming Chang, Kathryn M Connor, et al.Sleep Medicine|May 21, 2016
Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 dataEllen Snyder, Junshui Ma, Vladimir Svetnik, et al.Journal of Psychopharmacology (Oxford, England)|December 31, 2002
Efficacy of olanzapine in social anxiety disorder: a pilot studyStewart D Barnett, Michelle L Kramer, Charles D Casat, et al.Pageof 6